Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - iopromide, quantity: 498.72 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; sodium calcium edetate; dilute hydrochloric acid; sodium hydroxide - indications: ultravist is indicted for all angiographic and urographic examinations and for contrast enhancements in computerised tomography. ultravist 240 is additionally indicated for lumbar myelography in adults.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - iopromide, quantity: 498.72 mg/ml - injection, solution - excipient ingredients: dilute hydrochloric acid; water for injections; trometamol; sodium calcium edetate; sodium hydroxide - indications: ultravist is indicated for all angiographic and urographic examinations and for contrast enhancements in computerised tomography. ultravist 240 is additionally indicated for lumbar myelography in adults.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: glucose; disodium edetate; dispersible cellulose; polysorbate 80; purified water; hydrochloric acid; potassium sorbate - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 0.64 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; disodium edetate; glucose; purified water; hydrochloric acid; dispersible cellulose; polysorbate 80 - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 23.4 mg/ml (equivalent: abacavir, qty 20 mg/ml) - oral liquid, solution - excipient ingredients: sorbitol solution (70 per cent) (non-crystallising); sorbitol solution (70 per cent) (crystallising); propylene glycol; sodium citrate dihydrate; citric acid; methyl hydroxybenzoate; propyl hydroxybenzoate; saccharin sodium; hydrochloric acid; sodium hydroxide; purified water; flavour - ziagen (abacavir) is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children (see clinical trials). this indication is based on surrogate endpoints in studies up to 48 weeks in duration.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - temazepam, quantity: 10 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; maize starch; magnesium stearate - adjunctive therapy for the short term management of insomnia in adults.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - itraconazole, quantity: 10 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; hydroxypropylbetadex; saccharin sodium; purified water; caramel; sorbitol solution (70 per cent) (non-crystallising); sodium hydroxide; hydrochloric acid; flavour - sporanox oral solution is indicated for: * the treatment of oral and/or oesophageal candidiasis in hiv-positive or other immunocompromised patients. * prophylaxis of fungal infections in neutropenic patients.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium citrate dihydrate; benzalkonium chloride; hyetellose; water for injections; sodium hydroxide - trusopt eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open- angle glaucoma.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - iopromide, quantity: 768.86 mg/ml - injection, solution - excipient ingredients: trometamol; dilute hydrochloric acid; water for injections; sodium calcium edetate; sodium hydroxide - all angiographic and urographic examinations and for contrast enhancement in computerised tomography.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - framycetin sulfate, quantity: 5 mg/ml - eye and ear drops - excipient ingredients: sodium citrate dihydrate; sodium chloride; benzalkonium chloride; citric acid monohydrate; water for injections - in the eye: conjunctivitis, blepharitis, styes, corneal abrasions and burns. prophylactically following removal of foreign bodies. also indicated for corneal ulcers.in the ear: otitis externa.